Description: Naltrexone is an opiate antagonist used in the treatment of opiate and alcohol addiction. It blocks the effects of opiates so that if a user chooses to take an opiate after taking naltrexone, they do not experience much (any) effect. This helps improve abstinence in those who can maintain taking the daily dose of naltrexone. ((5a)-17-(cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxymorphinan-6-one)
recent news on the topic of $naltrexone (Sun Oct 12 02:52:12 PDT 2008
)
Orexigen presents positive results from Phase I trials of weight ...
*************** (US) Improved tolerability was suggested amongst those who received naltrexone SR/bupropion SR than those receiving the prior Phase II formulation containing naltrexone IR. (Tue Oct 07 19:03:38 2008 PDT)
![:-] Bot! - home](/bot/images/dsbotface1.gif ":-] Bot! - home")
